The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis 

Last month, a University of Oxford meta-analysis published in The BMJ examining 37 studies with over 9,000 participants found that patients who stopped taking GLP-1s were likely to gain approximately 1 pound per month, returning to their previous weight within two years.  However, data shared with Reuters ahead of peer review shows this may not… The post The ‘forever drug’ assumption about GLP-1s may be wrong, according to nference analysis  appeared first on Drug Discovery and Development.

Continue reading →